Skip to main content

Crisis Looms in Antibiotics as Drug Makers Go Bankrupt

By The New York Times  
   December 26, 2019

At a time when germs are growing more resistant to common antibiotics, many companies that are developing new versions of the drugs are hemorrhaging money and going out of business, gravely undermining efforts to contain the spread of deadly, drug-resistant bacteria.

Full story

Get the latest on healthcare leadership in your inbox.